Skip to main content

Oncology Medicine Distribution Across Nigeria

MediCore Distribution Services connects international pharmaceutical manufacturers with Nigerian hospitals and oncology centres, supplying essential chemotherapy and specialty medicines through a compliance-led wholesale distribution model.

What We Do

MediCore Distribution Services Limited is a PCN-licensed pharmaceutical wholesale distributor focused exclusively on oncology and specialty medicines. Based in Abeokuta, Ogun State, we operate as the supply link between international manufacturers of essential cancer medicines and the Nigerian healthcare facilities that need them.

Our portfolio covers platinum-based chemotherapy agents, taxanes, antimetabolites, supportive oncology medicines, oral and endocrine therapies, and a growing pipeline of targeted specialty products, all sourced from EU-GMP and WHO-GMP accredited manufacturers.

We work with hospital pharmacy departments, oncology centres, and specialist pharmacies to understand supply requirements and treatment protocols, ensuring consistent availability of the medicines clinicians depend on to deliver cancer care across Nigeria.

Every aspect of our operation, from manufacturer qualification and sourcing discipline to pharmacist-supervised handling and nationwide logistics, is built around compliance, reliability, and the practical needs of oncology practice.

Why MediCore

MediCore is built around the specific requirements of oncology medicine distribution, a discipline that demands rigorous compliance, specialist handling, and an unwavering commitment to supply reliability.

Compliance-Led Operations

PCN-licensed wholesale distribution with pharmacist-supervised handling and documented quality processes throughout the supply chain.

Oncology Focus

We specialise in oncology and specialty medicines. Our team, processes, and infrastructure are designed around the requirements of cancer treatment supply.

Disciplined Sourcing

All products are sourced exclusively from EU-GMP and WHO-GMP accredited manufacturers, ensuring pharmaceutical quality and regulatory alignment.

Reliable Distribution

Nationwide delivery to hospitals and oncology centres with supply coordination designed to minimise treatment disruption and stock shortages.

Regulatory Alignment

Active alignment with NAFDAC requirements and PCN guidelines, supporting manufacturers and healthcare providers through Nigeria's regulatory landscape.

Nigerian Market Expertise

Deep understanding of Nigerian healthcare procurement, institutional supply chains, and the practical challenges of oncology medicine access in West Africa.

Oncology Product Portfolio

MediCore distributes a focused range of essential oncology medicines covering the core treatment categories used in Nigerian cancer care, from platinum-based chemotherapy and taxanes to oral therapies and supportive medicines.

All products are sourced from EU-GMP and WHO-GMP manufacturers and are available subject to NAFDAC registration status and current stock levels.

View Full Product Portfolio
  • Platinum-based chemotherapy agents (carboplatin, cisplatin, oxaliplatin)
  • Taxanes (paclitaxel, docetaxel)
  • Antimetabolites and cytotoxic agents
  • Supportive oncology medicines
  • Oral and endocrine therapies
  • Targeted and specialty pipeline products

Compliance and Quality at Every Step

From manufacturer qualification and product sourcing to pharmacist-supervised storage and nationwide distribution, every step of the MediCore supply chain is governed by documented compliance processes and regulatory alignment.

Our Compliance Standards

Ready to Discuss Your Oncology Supply Needs?

Whether you are a hospital procurement team, an oncology centre, or an international manufacturer, we are ready to discuss how MediCore can support your requirements in Nigeria.